REGENXBIO Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	36.49	34.47	57.53	34.52	96.95	345.21
Short-Term Investments	69.03	195.6	177.16	240.74	267.69	112.23
Cash & Short-Term Investments	105.52	230.07	234.69	275.26	364.64	457.44
Cash Growth	-67.36%	-1.97%	-14.74%	-24.51%	-20.29%	-3.85%
Accounts Receivable	106.75	26.38	20.47	24.79	28.08	28.51
Other Receivables	10.88	11.88	12.4	19.3	8.5	-
Receivables	117.64	38.25	32.87	44.09	36.59	28.51
Prepaid Expenses	11.9	11.93	9.07	14.52	13.9	18.75
Other Current Assets	0.87	1.03	1.38	1.11	0.85	14.12
Total Current Assets	236.16	281.28	278	334.97	415.98	518.83
Property, Plant & Equipment	142.32	152.01	171.31	192.59	206.8	192.45
Long-Term Investments	-	10.79	10.18	38.87	200.56	391.91
Long-Term Accounts Receivable	0.44	2.31	0.47	0.7	1.5	2.26
Other Long-Term Assets	7.71	6.64	6.03	6.84	8.43	8.46
Total Assets	386.62	453.03	465.99	573.97	833.27	1,114
Accounts Payable	15.55	21.36	22.8	22.79	27.21	11.39
Accrued Expenses	23.03	38.36	37.91	49.32	45.99	59.5
Current Portion of Long-Term Debt	26.77	39.61	34.31	50.57	48.6	37.89
Current Portion of Leases	7.36	8.29	7.9	7.07	6	1.75
Current Income Taxes Payable	-	-	-	-	-	11.33
Current Unearned Revenue	9.88	10.45	0.12	0.15	1.83	3.33
Other Current Liabilities	0.05	0.03	0.16	0.39	0.81	5.29
Total Current Liabilities	82.62	118.1	103.19	130.27	130.43	130.47
Long-Term Debt	154.75	147.41	25.38	43.49	89.01	133.46
Long-Term Leases	61.6	65.22	74.13	82.22	88.8	84.93
Long-Term Unearned Revenue	15.4	18.94	-	-	-	-
Other Long-Term Liabilities	0.49	0.64	3.64	6.25	8.83	0.75
Total Liabilities	314.85	350.3	206.34	262.23	317.07	349.61
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	1,266	1,229	1,193	1,021	973.15	928.1
Retained Earnings	-1,193	-1,126	-932.15	-705.05	-441.55	-161.23
Comprehensive Income & Other	-0.88	-0.69	-0.74	-4.43	-15.4	-2.57
Shareholders' Equity	71.77	102.73	259.65	311.74	516.2	764.3
Total Liabilities & Equity	386.62	453.03	465.99	573.97	833.27	1,114
Total Debt	250.46	260.52	141.72	183.34	232.41	258.03
Net Cash (Debt)	-144.95	-19.66	103.15	130.79	332.8	591.32
Net Cash Growth	-	-	-21.13%	-60.70%	-43.72%	130.45%
Net Cash Per Share	-2.78	-0.38	2.08	2.99	7.71	13.47
Filing Date Shares Outstanding	66.01	51.61	50.09	44.43	43.46	42.95
Total Common Shares Outstanding	54.16	50.89	49.55	44.05	43.3	42.83
Working Capital	153.54	163.19	174.81	204.7	285.54	388.35
Book Value Per Share	1.32	2.02	5.24	7.08	11.92	17.84
Tangible Book Value	71.77	102.73	259.65	311.74	516.2	764.3
Tangible Book Value Per Share	1.32	2.02	5.24	7.08	11.92	17.84
Machinery	90.64	90.44	88.42	87.38	83.68	68.05
Leasehold Improvements	101.74	101.61	101.47	101.93	99.4	92.54

SEC Filings: 10-K · 10-Q